Alternatives to Cellcolabs

Leveraging the adaptive immune system to diagnose and treat disease.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

AI-powered platform for antibody discovery and development to create new medicines.

Biotechnology company specializing in antibody discovery and development with integrated 'Idea to IND' solutions.

A global oncology company developing and commercializing innovative cancer treatments.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

Developing engineered biologics to harness the immune system for disease treatment.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

Advance every cancer decision.

Gene therapy company developing transformative treatments for severe genetic diseases.

PFx Biotech is developing a novel platform for the discovery and development of protein-based therapeutics.

Gene therapy company developing treatments for rare inherited diseases.

Mining biological information for transformative peptide medicines.